Digital Therapeutics in the Diabetes Market

$129.00

Access Market Intelligence’s inaugural Digital Therapeutics Insight line focuses on DTx in the commercial insurance market. Our service includes an industry database, landscape and trend reports, custom research, and strategy consulting with an emphasis on market access and reimbursement.

AMI’s first report in this series: Digital Therapeutics in the Diabetes Market, provides a brief overview of the Diabetes market as well as profiles of the digital therapeutic companies offering products and services in the market. The report also includes brief profiles of the companies partnering with digital therapeutic companies in the diabetes market.